Q3 2024 |
68 |
$3.63B |
+$194M |
-$379M |
-$185M |
FI, BN, BRKB, MCK, CMCSA
|
13F-HR |
10/15/2024, 05:43 PM |
Q2 2024 |
58 |
$3.51B |
+$256M |
-$371M |
-$115M |
MCK, MSFT, FI, BRKB, BN
|
13F-HR |
7/23/2024, 02:43 PM |
Q1 2024 |
61 |
$3.69B |
+$151M |
-$349M |
-$198M |
MCK, BRKB, FI, CMCSA, MSFT
|
13F-HR |
4/15/2024, 08:59 PM |
Q4 2023 |
60 |
$3.45B |
+$337M |
-$353M |
-$15.4M |
MCK, CMCSA, BRKB, BN, MSFT
|
13F-HR |
1/12/2024, 10:51 AM |
Q3 2023 |
49 |
$3.35B |
+$489M |
-$478M |
+$10.9M |
BRKB, MCK, CMCSA, MSFT, MKL
|
13F-HR |
10/13/2023, 10:36 AM |
Q2 2023 |
51 |
$3.33B |
+$265M |
-$290M |
-$24.3M |
MCK, BRKB, MSFT, CMCSA, MKL
|
13F-HR |
7/24/2023, 01:48 PM |
Q1 2023 |
48 |
$3.17B |
+$253M |
-$175M |
+$78.4M |
MCK, BRKB, MSFT, ORCL, BKNG
|
13F-HR |
4/14/2023, 02:40 PM |
Q4 2022 |
51 |
$3.06B |
+$171M |
-$91.1M |
+$79.7M |
MCK, BRKB, CVS, CNC, MKL
|
13F-HR |
2/3/2023, 07:06 PM |
Q3 2022 |
50 |
$2.65B |
+$231M |
-$237M |
-$5.43M |
MCK, BRKB, CVS, CNC, MSFT
|
13F-HR |
10/25/2022, 08:21 AM |
Q2 2022 |
49 |
$2.93B |
+$94.2M |
-$206M |
-$112M |
MCK, MSFT, BRKB, CVS, CNC
|
13F-HR |
7/18/2022, 09:11 PM |
Q1 2022 |
49 |
$3.37B |
+$157M |
-$136M |
+$20.9M |
MSFT, BRKB, MCK, CVS, MKL
|
13F-HR |
4/12/2022, 07:53 PM |
Q4 2021 |
52 |
$3.37B |
+$238M |
-$347M |
-$109M |
MSFT, BRKB, MCK, CVS, AAP
|
Restatement |
1/20/2022, 04:01 PM |
Q3 2021 |
48 |
$3.17B |
+$147M |
-$212M |
-$65.9M |
MSFT, BRKB, AAP, CMCSA, MCK
|
13F-HR |
10/14/2021, 05:18 PM |
Q2 2021 |
49 |
$3.29B |
+$360M |
-$171M |
+$189M |
MSFT, BRKB, CMCSA, AAP, CVS
|
13F-HR |
7/16/2021, 04:55 PM |
Q1 2021 |
50 |
$2.89B |
+$202M |
-$122M |
+$79.7M |
MSFT, BRKB, CMCSA, MCK, AAP
|
13F-HR |
4/14/2021, 09:32 AM |
Q4 2020 |
47 |
$2.66B |
+$390M |
-$307M |
+$82.6M |
MSFT, BRKB, CMCSA, MCK, ORCL
|
13F-HR |
1/19/2021, 09:23 PM |
Q3 2020 |
39 |
$2.32B |
+$210M |
-$295M |
-$85.2M |
MSFT, BRKB, CMCSA, MCK, ORCL
|
13F-HR |
10/19/2020, 10:33 AM |
Q2 2020 |
36 |
$2.23B |
+$115M |
-$177M |
-$62M |
MSFT, MCK, BRKB, CMCSA, ORCL
|
13F-HR |
7/16/2020, 04:59 PM |
Q1 2020 |
41 |
$2B |
+$449M |
-$569M |
-$119M |
MSFT, BRKB, MCK, CMCSA, ORCL
|
13F-HR |
5/5/2020, 05:15 PM |
Q4 2019 |
37 |
$2.56B |
+$125M |
-$175M |
-$50.5M |
MSFT, BRKB, KSU, BKNG, AON
|
13F-HR |
2/13/2020, 05:06 PM |
Q3 2019 |
38 |
$2.45B |
+$161M |
-$333M |
-$171M |
MSFT, BRKB, KSU, AON, CMCSA
|
13F-HR |
11/13/2019, 04:32 PM |
Q2 2019 |
36 |
$2.54B |
+$251M |
-$410M |
-$158M |
MSFT, AON, BRKB, KSU, CMCSA
|
13F-HR |
8/13/2019, 05:01 PM |
Q1 2019 |
43 |
$2.59B |
+$191M |
-$396M |
-$204M |
MSFT, AON, CDK, KSU, CTSH
|
13F-HR |
5/14/2019, 04:49 PM |
Q4 2018 |
43 |
$2.52B |
+$325M |
-$416M |
-$91.1M |
MSFT, AON, DLTR, BRKB, HSY
|
13F-HR |
2/13/2019, 05:21 PM |
Q3 2018 |
43 |
$2.87B |
+$137M |
-$347M |
-$211M |
MSFT, AON, ORCL, CMCSA, WBA
|
13F-HR |
11/13/2018, 05:59 PM |
Q2 2018 |
42 |
$2.8B |
+$210M |
-$953M |
-$744M |
MSFT, ORCL, AON, CMCSA, HSY
|
13F-HR |
8/13/2018, 04:36 PM |
Q1 2018 |
44 |
$3.56B |
+$392M |
-$1.13B |
-$733M |
MSFT, ORCL, AON, CMCSA, TWX
|
13F-HR |
5/14/2018, 04:18 PM |
Q4 2017 |
57 |
$4.41B |
+$621M |
-$442M |
+$179M |
MSFT, ORCL, BRKB, CMCSA, LB
|
13F-HR |
2/13/2018, 08:43 PM |
Q3 2017 |
45 |
$4.12B |
+$109M |
-$270M |
-$161M |
ORCL, MSFT, BRKB, AON, DG
|
13F-HR |
11/13/2017, 05:32 PM |
Q2 2017 |
47 |
$4.26B |
+$372M |
-$442M |
-$70.8M |
ORCL, BRKB, MSFT, AON, AGN
|
13F-HR |
8/14/2017, 04:19 PM |
Q1 2017 |
44 |
$4.18B |
+$174M |
-$428M |
-$253M |
BRKB, ORCL, MSFT, AAPL, PCLN
|
13F-HR |
5/12/2017, 06:13 PM |
Q4 2016 |
43 |
$4.31B |
+$522M |
-$485M |
+$36.7M |
MSFT, ORCL, BRKB, CMCSA, AAP
|
13F-HR |
2/13/2017, 04:46 PM |
Q3 2016 |
41 |
$4.31B |
+$176M |
-$433M |
-$256M |
BRKB, ORCL, MSFT, CMCSA, PCLN
|
13F-HR |
11/14/2016, 11:25 AM |
Q2 2016 |
55 |
$4.45B |
+$371M |
-$371M |
-$289K |
ORCL, BRKB, MSFT, AON, CMCSA
|
13F-HR |
8/12/2016, 04:24 PM |
Q1 2016 |
55 |
$4.25B |
+$482M |
-$379M |
+$103M |
ORCL, BRKB, MSFT, NLSN, AON
|
13F-HR |
5/13/2016, 05:00 PM |
Q4 2015 |
60 |
$4.19B |
+$679M |
-$458M |
+$221M |
MSFT, AGN, BRKB, NLSN, AIG
|
13F-HR |
2/12/2016, 04:09 PM |
Q3 2015 |
52 |
$3.81B |
+$945M |
-$705M |
+$239M |
AAP, MSFT, NLSN, MSI, AAPL
|
13F-HR |
11/13/2015, 04:36 PM |
Q2 2015 |
51 |
$3.9B |
+$652M |
-$356M |
+$296M |
MSFT, AIG, AAPL, AAP, CVS
|
13F-HR |
8/13/2015, 04:07 PM |
Q1 2015 |
53 |
$3.61B |
+$566M |
-$378M |
+$188M |
CHL, AAPL, MSFT, CVS, CTSH
|
13F-HR |
5/14/2015, 04:10 PM |
Q4 2014 |
52 |
$3.25B |
+$728M |
-$332M |
+$396M |
AGN, AAP, CHL, ORCL, CTSH
|
13F-HR |
2/13/2015, 04:51 PM |
Q3 2014 |
43 |
$2.83B |
+$585M |
-$393M |
+$192M |
AGN, CHL, MSFT, EBAY, CVS
|
13F-HR |
11/13/2014, 04:03 PM |
Q2 2014 |
40 |
$2.57B |
+$302M |
-$45.6M |
+$256M |
AGN, AAPL, HAL, MSFT, APA
|
13F-HR |
8/13/2014, 04:13 PM |
Q1 2014 |
36 |
$2.25B |
+$269M |
-$325M |
-$55.9M |
MSFT, HAL, VYX, CVS, AAPL
|
13F-HR |
5/14/2014, 03:51 PM |
Q4 2013 |
37 |
$2.24B |
$0 |
$0 |
|
AGN, CVS, AAPL, MSFT, CHKP
|
13F-HR |
2/12/2014, 02:09 PM |